150 related articles for article (PubMed ID: 8131836)
1. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y
Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993
[TBL] [Abstract][Full Text] [Related]
3. Effects of herbimycin A and various SH-reagents on p60v-src kinase activity in vitro.
Fukazawa H; Mizuno S; Uehara Y
Biochem Biophys Res Commun; 1990 Nov; 173(1):276-82. PubMed ID: 2175179
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells.
Okabe M; Uehara Y; Noshima T; Itaya T; Kunieda Y; Kurosawa M
Leuk Res; 1994 Nov; 18(11):867-73. PubMed ID: 7967714
[TBL] [Abstract][Full Text] [Related]
5. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.
Uehara Y; Fukazawa H; Murakami Y; Mizuno S
Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121
[TBL] [Abstract][Full Text] [Related]
6. Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth.
Okabe M; Uehara Y; Miyagishima T; Itaya T; Tanaka M; Kuni-Eda Y; Kurosawa M; Miyazaki T
Blood; 1992 Sep; 80(5):1330-8. PubMed ID: 1515646
[TBL] [Abstract][Full Text] [Related]
7. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
An WG; Schulte TW; Neckers LM
Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
[TBL] [Abstract][Full Text] [Related]
8. New insight into oncoprotein-targeted antitumor effect: herbimycin A as an antagonist of protein tyrosine kinase against Ph1-positive leukemia cells.
Okabe M; Uehara M
Leuk Lymphoma; 1993 Dec; 12(1-2):41-9. PubMed ID: 8161936
[TBL] [Abstract][Full Text] [Related]
9. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system.
Hamaguchi M; Matsuyoshi N; Ohnishi Y; Gotoh B; Takeichi M; Nagai Y
EMBO J; 1993 Jan; 12(1):307-14. PubMed ID: 8381351
[TBL] [Abstract][Full Text] [Related]
10. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T
Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193
[TBL] [Abstract][Full Text] [Related]
11. Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N
Leuk Res; 1994 Mar; 18(3):221-8. PubMed ID: 8139288
[TBL] [Abstract][Full Text] [Related]
12. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of 5-S-GAD on phosphorylation of V-SRC and BCR-ABL tyrosine kinase.
Leem JY; Park HY; Fukazawa H; Uehara Y; Natori S
Biol Pharm Bull; 1998 Jul; 21(7):784-5. PubMed ID: 9703270
[TBL] [Abstract][Full Text] [Related]
14. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.
Sepp-Lorenzino L; Ma Z; Lebwohl DE; Vinitsky A; Rosen N
J Biol Chem; 1995 Jul; 270(28):16580-7. PubMed ID: 7622464
[TBL] [Abstract][Full Text] [Related]
15. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
Uehara Y; Fukazawa H
Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554
[No Abstract] [Full Text] [Related]
16. Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor.
Honma Y; Matsuo Y; Hayashi Y; Omura S
Int J Cancer; 1995 Mar; 60(5):685-8. PubMed ID: 7860143
[TBL] [Abstract][Full Text] [Related]
17. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
[TBL] [Abstract][Full Text] [Related]
18. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
19. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.
Yoneda T; Lowe C; Lee CH; Gutierrez G; Niewolna M; Williams PJ; Izbicka E; Uehara Y; Mundy GR
J Clin Invest; 1993 Jun; 91(6):2791-5. PubMed ID: 8514886
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
